JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M210210200 on February 24, 2003

J. Biol. Chem., Vol. 278, Issue 18, 15550-15557, May 2, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/18/15550    most recent
M210210200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-j.
Right arrow Articles by Lairmore, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-j.
Right arrow Articles by Lairmore, M. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Conserved Calcineurin-binding Motif in Human T Lymphotropic Virus Type 1 p12I Functions to Modulate Nuclear Factor of Activated T Cell Activation*

Seung-jae KimDagger , Wei DingDagger , Björn AlbrechtDagger §, Patrick L. GreenDagger ||, and Michael D. LairmoreDagger ||**

From the Dagger  Center for Retrovirus Research and Department of Veterinary Biosciences,  Comprehensive Cancer Center, The Arthur G. James Cancer Hospital and Solove Research Institute, and the || Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University, Columbus, Ohio 43210-1093

The PXIXIT calcineurin binding motif or highly related sequences are found in a variety of calcineurin-binding proteins in yeast, mammalian cells, and viruses. The accessory protein p12I encoded in the HTLV-1 pX ORF I promotes T cell activation during the early stages of HTLV-1 infection by activating nuclear factor of activated T cells (NFAT) through calcium release from the endoplasmic reticulum. We identified in p12I, a conserved motif, which is highly homologous with the PXIXIT calcineurin-binding motif of NFAT. Both immunoprecipitation and calmodulin agarose bead pull-down assays indicated that wild type p12I and mutants of p12I that contained the motif-bound calcineurin. In addition, an alanine substitution p12I mutant (p12I AXAXAA) had greatly reduced binding affinity for calcineurin. We then tested whether p12I binding to calcineurin affected NFAT activity. p12I competed with NFAT for calcineurin binding in calmodulin bead pull-down experiments. Furthermore, the p12I AXAXAA mutant enhanced NFAT nuclear translocation compared with wild type p12I and increased NFAT transcriptional activity 2-fold greater than wild type p12I. Similar to NFAT, endogenous calcineurin phosphatase activity was increased in Jurkat T cells expressing p12I independent of its calcineurin binding property. Thus, the reduced binding of p12I to calcineurin allows enhanced nuclear translocation and transcription mediated by NFAT. Herein, we are the first to identify a retroviral protein that binds calcineurin. Our data suggest that HTLV-1 p12I modulates NFAT activation to promote early virus infection of T lymphocytes, providing a novel mechanism for retrovirus-mediated cell activation.


* This work was supported by National Institutes of Health Grants RR-14324, AI-01474, and CA-92009 (to M. D. L.) and NCI, National Institutes of Health, Grant CA-70529 (to the Ohio State University Comprehensive Cancer Center).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Howard Hughes Medical Institute, Molecular Pathogenesis Program, The Skirball Institute of Biomolecular Medicine, New York University Medical Center, New York, NY 10016.

** To whom correspondence should be addressed: Center for Retrovirus Research and Department of Veterinary Biosciences, The Ohio State University, 1925 Coffey Rd., Columbus, OH 43210-1093. Tel.: 614-292-4489; Fax: 614-292-6473; E-mail: Lairmore.1@osu.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
K. R. Jerome
Viral Modulation of T-Cell Receptor Signaling
J. Virol., May 1, 2008; 82(9): 4194 - 4204.
[Full Text] [PDF]


Home page
J. Virol.Home page
R. Fukumoto, M. Dundr, C. Nicot, A. Adams, V. W. Valeri, L. E. Samelson, and G. Franchini
Inhibition of T-Cell Receptor Signal Transduction and Viral Expression by the Linker for Activation of T Cells-Interacting p12I Protein of Human T-Cell Leukemia/Lymphoma Virus Type 1
J. Virol., September 1, 2007; 81(17): 9088 - 9099.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Miyazaki, J.-I. Yasunaga, Y. Taniguchi, S. Tamiya, T. Nakahata, and M. Matsuoka
Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5' Long Terminal Repeat during Oncogenesis
J. Virol., June 1, 2007; 81(11): 5714 - 5723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Czirjak and P. Enyedi
Targeting of Calcineurin to an NFAT-like Docking Site Is Required for the Calcium-dependent Activation of the Background K+ Channel, TRESK
J. Biol. Chem., May 26, 2006; 281(21): 14677 - 14682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Puri, B. S. Magenheimer, R. L. Maser, E. M. Ryan, C. A. Zien, D. D. Walker, D. P. Wallace, S. J. Hempson, and J. P. Calvet
Polycystin-1 Activates the Calcineurin/NFAT (Nuclear Factor of Activated T-cells) Signaling Pathway
J. Biol. Chem., December 31, 2004; 279(53): 55455 - 55464.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Waldele, G. Schneider, T. Ruckes, and R. Grassmann
Interleukin-13 Overexpression by Tax Transactivation: a Potential Autocrine Stimulus in Human T-Cell Leukemia Virus-Infected Lymphocytes
J. Virol., June 15, 2004; 78(12): 6081 - 6090.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. R. Silverman, A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion
J. Virol., April 15, 2004; 78(8): 3837 - 3845.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Ding, S.-J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation
J. Virol., October 15, 2003; 77(20): 11027 - 11039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.